Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA.

Hikal is a company built on enduring relationships. They are committed to delivering value as a complementary partner. By delivering on this commitment, they have earned the respect and recognition of leading companies from around the world.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries. It collaborates with innovator companies and offer solutions in Contract Research, Custom Synthesis and Custom Manufacturing. Its people have extensive expertise in multi-disciplinary project management.

 * Discovery Research Support It supplies molecules for discovery research on a contract basis. It is the preferred partner of leading multinational companies in different phases of new drug discovery and development. Backed by state-of-the-art instrumentation and an experienced team of scientists, we focus on research on new molecules.
 * Process Development It has a successful track record in developing non-infringing processes and scaling them up from laboratory to kilo scale to commercial scale production. Its engineering expertise enables it to successfully set up chemical plants, manage and develop a wide range of processes that conform to stringent quality and safety guidelines.
 * Analytical Method Development It undertakes method validation of new substances. The activities include in-process analysis, identification and quantification of impurities.
 * Custom Manufacturing It also undertakes custom manufacturing of key intermediates and active substances for pharmaceutical and agrochemical companies worldwide. Its intermediates are being used in new candidate drugs in Phase 1, Phase 2 and Phase 3 stage of clinical trials as well as in commercialized drugs.

Hikal Ltd.

Indoco Remedies Ltd.

Shilpa Medicare Ltd.

Sequent Scientific Ltd.

Advanced Enzyme Technologies Ltd.

Gufic Biosciences Ltd.

Unichem Laboratories Ltd.

Orchid Pharma Ltd.

IOL Chemicals And Pharmaceuticals Ltd.

Dishman Carbogen Amcis Ltd.

AMI Organics Ltd.

Morepen Laboratories Ltd.

RPG Life Sciences Ltd.

Supriya Lifescience Ltd.

Aarti Drugs Ltd.

Market Cap	3,356 Cr	ROE	7.1%
P/E Ratio(TTM)	41.0	EPS(TTM)	0.0
P/B Ratio	2.9	Dividend Yield	0.4%
Industry P/E	40.0	Book Value	92.9
		Face Value	2.0

Fundamentals